Sparse, poor evidence supports fumarates for psoriasis

Even though fumaric acid esters are increasingly considered to be a suitable, even a first-line, systemic treatment for moderate to severe psoriasis in some parts of Europe, the evidence supporting...

Source: Rheumatology News - March 15, 2016 Category: Rheumatology Source Type: research